Unknown

Dataset Information

0

Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.


ABSTRACT: Understanding the effects of immune responses on targeted delivery of nanoparticles is important for clinical translations of new cancer imaging and therapeutic nanoparticles. In this study, we found that repeated administrations of magnetic iron oxide nanoparticles (IONPs) conjugated with mouse or human derived targeting ligands induced high levels of ligand specific antibody responses in normal and tumor bearing mice while injections of unconjugated mouse ligands were weakly immunogenic and induced a very low level of antibody response in mice. Mice that received intravenous injections of targeted and polyethylene glycol (PEG)-coated IONPs further increased the ligand specific antibody production due to differential uptake of PEG-coated nanoparticles by macrophages and dendritic cells. However, the production of ligand specific antibodies was markedly inhibited following systemic delivery of theranostic nanoparticles carrying a chemotherapy drug, doxorubicin. Targeted imaging and histological analysis revealed that lack of the ligand specific antibodies led to an increase in intratumoral delivery of targeted nanoparticles. Results of this study support the potential of further development of targeted theranostic nanoparticles for the treatment of human cancers.

SUBMITTER: Yang E 

PROVIDER: S-EPMC4265747 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.

Yang Emmy E   Qian Weiping W   Cao Zehong Z   Wang Liya L   Bozeman Erica N EN   Ward Christina C   Yang Bin B   Selvaraj Periasamy P   Lipowska Malgorzata M   Wang Y Andrew YA   Mao Hui H   Yang Lily L  

Theranostics 20150101 1


Understanding the effects of immune responses on targeted delivery of nanoparticles is important for clinical translations of new cancer imaging and therapeutic nanoparticles. In this study, we found that repeated administrations of magnetic iron oxide nanoparticles (IONPs) conjugated with mouse or human derived targeting ligands induced high levels of ligand specific antibody responses in normal and tumor bearing mice while injections of unconjugated mouse ligands were weakly immunogenic and in  ...[more]

Similar Datasets

| S-EPMC5834183 | biostudies-literature
| S-EPMC4490273 | biostudies-literature
| S-EPMC5436521 | biostudies-literature
| S-EPMC4613746 | biostudies-literature
| S-EPMC8152631 | biostudies-literature
| S-EPMC7320870 | biostudies-literature
| S-EPMC5522072 | biostudies-other
| S-EPMC9299552 | biostudies-literature
| S-EPMC5342926 | biostudies-literature
| S-EPMC8229704 | biostudies-literature